BD Cathena IV Catheter (BD) – Septum Defect Risk (2025)

Check Your Product

According to the U.S. Food and Drug Administration (FDA)

Reason for Recall

As stated by FDA

Due to a manufacturing defect IV catheter may have a hole in the septum, which may result in blood leakage from the septum during insertion, which may cause blood exposure or the need for a second IV to be placed - which may result in therapy delay.

Recommended Action

Per FDA guidance

On 4/21/2025, Removal notices were sent (mail/email/fax/phone) to Medical Directors, Risk Managers, Medical Device Safety Officers, Nurse Managers, and distributors were informed of the following: - Routine clinical practice of PPE should protect the clinician from mucocutaneous blood exposure. - If leakage from the septum occurs during insertion, the PIVC should no longer be used. It is recommended the clinician places a new PIVC. In addition, they were asked to do the following: 1) Destroy all unused product subject to the recall following your institution's process for destruction. 2. For indwelling catheters, no further action is needed. 3. If a defective product was previously used on a patient with no issues, no further actions are needed. 4. Share this recall notification with all users within your facility network of the product to ensure they are also aware of this recall. 5. Complete and return Customer Response Form via email to Email: BDRC6@bd.com 6. Distributors were asked to identify all customers within their distribution network that purchased any affected product. Then, Provide a copy of the attached customer letter to all customers to advise them of this field action notification. Questions or complaints can be reported to the North American Regional Complaint Center, 1-844-823-5433 Mon Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com